Cabozantinib +/- Trastuzumab In Breast Cancer Patients w/ Brain Metastases
Clinical trial NCT02260531 · COMPLETED
Trial details
- NCT number
- NCT02260531
- Sponsor
- Dana-Farber Cancer Institute
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-11-01
- Primary completion
- 2019-01-04
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.